Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
The American Journal of Cardiology
|
March 30, 2013
Impact of adding ezetimibe to statin to achieve low-density lipoprotein cholesterol goal (from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] trial)
David J Maron, Pamela M Hartigan, David R Neff, et al.
Atherosclerosis
|
June 5, 2018
Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials
G B John Mancini, William E Boden, Maria M Brooks, et al.
Journal of the American College of Cardiology
|
April 27, 2019
Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes
G B John Mancini, David J Maron, Pamela M Hartigan, et al.
Circulation. Cardiovascular Quality and Outcomes
|
February 19, 2019
Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease
William S Weintraub, Pamela M Hartigan, G B John Mancini, et al.
Journal of the American College of Cardiology
|
November 3, 2018
Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial
David J Maron, G B John Mancini, Pamela M Hartigan, et al.
Journal of the American College of Cardiology
|
September 3, 2016
Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease
G B John Mancini, Michael E Farkouh, Maria M Brooks, et al.
The American Journal of Cardiology
|
July 14, 2020
Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease
William E Boden, Pamela M Hartigan, John Mancini, et al.
Journal of the American College of Cardiology
|
August 27, 2013
Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)
Subroto Acharjee, William E Boden, Pamela M Hartigan, et al.
Journal of the American College of Cardiology
|
November 6, 2020
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization
Michael E Farkouh, Lucas C Godoy, Maria M Brooks, et al.
The American Journal of Cardiology
|
September 28, 2015
Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial)
Santosh K Padala, Mandeep S Sidhu, Pamela M Hartigan, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
The American Journal of Cardiology
|
March 30, 2013
Impact of adding ezetimibe to statin to achieve low-density lipoprotein cholesterol goal (from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] trial)
David J Maron, Pamela M Hartigan, David R Neff, et al.
Atherosclerosis
|
June 5, 2018
Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials
G B John Mancini, William E Boden, Maria M Brooks, et al.
Journal of the American College of Cardiology
|
April 27, 2019
Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes
G B John Mancini, David J Maron, Pamela M Hartigan, et al.
Circulation. Cardiovascular Quality and Outcomes
|
February 19, 2019
Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease
William S Weintraub, Pamela M Hartigan, G B John Mancini, et al.
Journal of the American College of Cardiology
|
November 3, 2018
Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial
David J Maron, G B John Mancini, Pamela M Hartigan, et al.
Journal of the American College of Cardiology
|
September 3, 2016
Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease
G B John Mancini, Michael E Farkouh, Maria M Brooks, et al.
The American Journal of Cardiology
|
July 14, 2020
Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease
William E Boden, Pamela M Hartigan, John Mancini, et al.
Journal of the American College of Cardiology
|
August 27, 2013
Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)
Subroto Acharjee, William E Boden, Pamela M Hartigan, et al.
Journal of the American College of Cardiology
|
November 6, 2020
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization
Michael E Farkouh, Lucas C Godoy, Maria M Brooks, et al.
The American Journal of Cardiology
|
September 28, 2015
Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial)
Santosh K Padala, Mandeep S Sidhu, Pamela M Hartigan, et al.
Page
of 4